New Technology Predicts ICU Need for COVID-19 and General Ward Patients

The predictive analytic outperformed two similar technologies.

2:48 PM

Author | Noah Fromson

tye dye color background and drawing of clip board and magnifying glass in white

During yet another surge of COVID-19 cases and hospitalizations, open beds are precious commodities to ICU staff making triage decisions. Early intervention is key to stopping overflow.

In a study published in JMIR: Medical Informatics, researchers at MCIRCC found that their technology outperformed similar products used to predict deterioration for both general ward and COVID-19 patients requiring transfer to intensive care units. The analytic, known as PICTURE (Predicting ICU Transfer and other Unforeseen Events), was significantly more accurate at identifying when patients may need life-saving intervention than the Epic Deterioration Index (EDI), an existing product used for patient deterioration investigation.

PICTURE's machine learning algorithm crunches an array of data, including vital signs, lab results and demographic information to flag patients at the highest risk of decline. The model is able to explain what risk factors influence the prediction, helping clinicians respond faster. 

"The PICTURE model is able to integrate data from the electronic health record and transform it into meaningful predictions based on the patient's risk of experiencing an adverse outcome," says Brandon Cummings, a data scientist at MCIRCC. "This is especially important in the case of COVID-19 patients, who can deteriorate rapidly and unexpectedly. By predicting these events before they occur, PICTURE can give clinicians time to react and stabilize the patient before more drastic measures are required."

The study was the first PubMed indexed paper to report a direct, head-to-head comparison with Epic's EDI for COVID-19 patients. Researchers at MCIRCC are working to test PICTURE in other health systems and develop specialized versions of it for other populations, including rehabilitation and sepsis patients.

"The ability to anticipate these events will be valuable when considering potential future waves of COVID-19 infections," says Kevin Ward, M.D., executive director of MCIRCC. "However, the real value will be the continued use of PICTURE in all hospitalized patients no matter what the situation is."

DISCLOSURES: This study was supported in part by the Michigan Institute for Data Science. "Propelling Original Data Science (PODS) Mini-Grants for COVID-19 Research" award. Andrew Admon, M.D., M.P.H., M.Sc., has received funding from NIH/NHLBI.

CONFLICTS OF INTEREST: Christopher Gillies, Ph.D., Richard P. Medlin, Jr., M.D., M.S.I.S., and Kevin Ward, M.D., have submitted a patent regarding the machine learning methodologies presented in this paper through the University of Michigan's Office of Technology Transfer.

Paper cited: "Predicting Intensive Care Transfers and Other Unforeseen Events: Analytic Model Validation Study and Comparison to Existing Methods," JMIR Medical Informatics. DOI: 10.2196/25066


More Articles About:

Lab Notes All Research Topics Covid-19 Future Think Emerging Technologies infectious disease
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

red blood cells going through clear tube red background
Health Lab

FDA-approved drug offers hope for patients with polycythemia vera, a rare bone marrow disorder

FDA-approved rusfertide offers new hope for polycythemia vera patients by reducing phlebotomy dependence, easing symptoms, and improving daily life.
bats flying in air purple sky pink
Health Lab

Rabies is on the rise: Experts offer advice

With rabies on the rise, infectious disease experts from Michigan Medicine share advice.
cells close up blue and green background microscope
Health Lab

Engineered nanoparticles sensitize gliomas to radiotherapy

University of Michigan researchers discovered a new pathway that sensitizes mIDH1 gliomas to radiation in human and mouse mIDH1 glioma cells and mouse models, paving the way for phase 1 clinical trials in humans
blue person figure symptoms questioning and social media icons flashing moving
Health Lab

Have an MCAS diagnosis? Well, maybe not

A leading MCAS expert breaks down what mast cell activation syndrome is and how people may be getting over, and mis, diagnosed.
getty image of a woman bending over in a red seat in pain with green painted background
Health Lab

Who’s at risk for painful periods?

A University of Michigan-led study looked more closely at dysmenorrhea, which is pain that comes with menstruation, in girls before and after their first periods.
brain and stomach lining directions pointing
Health Lab

Identifying avoidant, restrictive food intake disorder in gastroenterology patients

New research from Michigan Medicine gastroenterologists attempts to better calibrate the Nine-Item ARFID Screen for patients with disorders of gut-brain interaction.